Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
Jinfeng KongXiuhui LiangJinyu ZhangJinhua ZengJingfeng LiuJianxing ZengPublished in: Digestive diseases and sciences (2021)
Among patients who underwent curative hepatectomy for HBV-related HCC with MVI, postoperative adjuvant AVT was the independent protective factor associated with mortality and tumor recurrence. Given the high rate of postoperative recurrence and poor prognosis of HBV-related HCC with MVI, our findings may have useful clinical significance in the prevention of tumor recurrence in these patients.
Keyphrases
- poor prognosis
- free survival
- hepatitis b virus
- end stage renal disease
- long non coding rna
- patients undergoing
- prognostic factors
- newly diagnosed
- ejection fraction
- chronic kidney disease
- early stage
- liver failure
- peritoneal dialysis
- stem cells
- cardiovascular disease
- risk factors
- cell migration
- rectal cancer
- mesenchymal stem cells
- bone marrow
- patient reported
- data analysis